Takeda Pharmaceutical Co., Ltd.

50
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3463000004
JPY
4,471.00
-24 (-0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Takeda Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
179,070.00
46,318.00
383,720.00
317,938.00
366,159.00
-60,754.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-69,479.00
-263,559.00
-114,042.00
140,014.00
313,567.00
117,192.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
962,493.00
640,321.00
877,217.00
1,021,218.00
905,073.00
555,410.00
Cash Flow from Investing Activities
-385,355.00
-488,214.00
-615,718.00
-204,445.00
392,038.00
279,250.00
Cash Flow from Financing Activities
-638,441.00
-254,041.00
-600,593.00
-962,058.00
-981,004.00
-878,002.00
Net Cash Inflow / Outflow
-72,688.00
-75,730.00
-316,165.00
-116,527.00
328,608.00
-65,108.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-11,385.00
26,204.00
22,929.00
28,758.00
12,501.00
-21,766.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Takeda Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
179070
543034
-3,63,964.00
-67.02%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-69479
-28843
-40,636.00
-140.89%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
962493
450290
5,12,203.00
113.75%
Cash Flow from Investing Activities
-385355
-230149
-1,55,206.00
-67.44%
Cash Flow from Financing Activities
-638441
-140912
-4,97,529.00
-353.08%
Net Cash Inflow / Outflow
-72688
81528
-1,54,216.00
-189.16%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-11385
2299
-13,684.00
-595.22%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 50.31% vs -27.01% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
9,62,493.00
6,40,321.00
50.31%